Alfresa Holdings Corporation (TYO:2784)

Market Cap	393.78B -1.0%
Revenue (ttm)	3.10T +4.8%
Net Income	41.75B +52.4%
EPS	229.64 +55.6%
Shares Out	181.72M
PE Ratio	9.44
Forward PE	16.67
Dividend	68.00 (3.14%)
Ex-Dividend Date	Mar 30, 2026

Volume	n/a
Open	2,173.00
Previous Close	2,167.00
Day's Range	2,156.00 - 2,193.00
52-Week Range	1,913.00 - 2,685.50
Beta	-0.17
Analysts	Hold
Price Target	2,500.00 (+14.94%)
Earnings Date	May 15, 2026

About Alfresa Holdings

Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is also involved in the operation of dispensing pharmacies and conducting related businesses; ethical pharmaceuticals wholesaling business; self-medication products wholesaling business; and other medical-related businesses. In addition, the company manufactures and markets active pharmaceutical ingredients; contract dis...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2003
• Employees: 12,452
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 2784

Financial Performance

In fiscal year 2026, Alfresa Holdings's revenue was 3.10 trillion, an increase of 4.83% compared to the previous year's 2.96 trillion. Earnings were 41.75 billion, an increase of 52.42%.